1. Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment
   Xiaoyan Pan et al, 2013, Metabolomics CrossRef
2. A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapy
   YU PENG et al, 2015, Oncology Letters CrossRef
3. Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials
   Adnan M. Nagrial et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
4. Efficacy and Safety of Camrelizumab in Combination with Docetaxel + S-1 Sequenced by Camrelizumab + S-1 for Stage III (PD-1+/MSI-H/EBV+/dMMR) Gastric Cancer: Study Protocol for a Single-Center, Prospective, Open-Label, Single-Arm Trial
   Zhongyi Dong et al, 2022, Frontiers in Surgery CrossRef
5. S-1 plus CIK as second-line treatment for advanced pancreatic cancer
   Meng Wang et al, 2013, Medical Oncology CrossRef
6. A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer
   Naminatsu Takahara et al, 2013, Cancer Chemotherapy and Pharmacology CrossRef